Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride for Prostate Cancer Prevention in HPIN
NCT00780754Phase 3Completed
- Sponsor
- Lithuanian University of Health Sciences
- Start
- Apr 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dutasteride in prostate cancer (PCa), sponsored by Lithuanian University of Health Sciences. Started Apr 2007; status: completed.
02
Drugs
dutasteride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00780754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00780754.